Home > News > BioSante Pharmaceuticals To Present At Investor Conference
February 23rd, 2004
BioSante Pharmaceuticals To Present At Investor Conference
BioSante Pharmaceuticals announced today that Stephen M. Simes, its president and chief executive officer, is scheduled to present at the BIO CEO & Investor Conference at the Waldorf-Astoria Hotel in New York on Wednesday, February 25, at 9:30 a.m. EST. Mr. Simes will discuss BioSante's progress with its hormone therapy products and its nanotechnology-based drug and vaccine delivery systems.
Arrowhead to Present at BioCentury's NewsMakers in the Biotech Industry Conference September 19th, 2014
SouthWest NanoTechnologies (SWeNT) Receives NIST Small Business Innovation Research (SBIR) Phase 1 Award to Produce Greater than 99% Semiconducting Single-Wall Carbon Nanotubes September 19th, 2014
Toward optical chips: A promising light source for optoelectronic chips can be tuned to different frequencies September 19th, 2014
New research points to graphene as a flexible, low-cost touchscreen solution September 19th, 2014